siRNA-mediated inhibition of either FRA-2 or JUND expression resulted in a decrease in cell proliferation and a dampening of CCR4 and MDM2 expression in CTCL cell lines [122]. This evidence concerns the gene JUND and primary cutaneous T-cell non-Hodgkin lymphoma.